Dune Medical touts prostate cancer study

Dune Medical Devices of Framingham has announced that results of a published study[1] of its MarginProbe technology for use in prostate cancer surgery show the device’s ability to discriminate between cancer and healthy tissue with “a very high degree of accuracy.”

Dune Medical Devices of Framingham has announced that results of a published study of its MarginProbe technology for use in prostate cancer surgery show the device’s ability to discriminate between cancer and healthy tissue with “a very high degree of accuracy.”